doi: 10.1097/00002826-199201001-00226.
Reversible monoamine-A inhibitors in panic disorder
Affiliations
- PMID: 1498904
- DOI: 10.1097/00002826-199201001-00226
Item in Clipboard
Reversible monoamine-A inhibitors in panic disorder
Clin Neuropharmacol.
1992.
No abstract available
Similar articles
-
Reversible monoamine oxidase-A inhibitors in panic disorder.Clin Neuropharmacol. 1993;16 Suppl 2:S77-82. Clin Neuropharmacol. 1993. PMID: 8313401 Clinical Trial.
-
The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.J Clin Psychopharmacol. 1994 Feb;14(1):74-5. doi: 10.1097/00004714-199402000-00011. J Clin Psychopharmacol. 1994. PMID: 8151007 Clinical Trial. No abstract available.
-
Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.Int Clin Psychopharmacol. 1997 Oct;12 Suppl 6:S27-30. Int Clin Psychopharmacol. 1997. PMID: 9466172 Clinical Trial.
-
[Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].Nervenarzt. 1996 May;67(5):339-47. Nervenarzt. 1996. PMID: 9005342 Review. German.
-
Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders.Acta Psychiatr Scand Suppl. 1990;360:29-34. doi: 10.1111/j.1600-0447.1990.tb05321.x. Acta Psychiatr Scand Suppl. 1990. PMID: 2248064 Review.
Cited by
-
Panic disorder.Curr Psychiatry Rep. 2001 Aug;3(4):295-301. doi: 10.1007/s11920-001-0022-1. Curr Psychiatry Rep. 2001. PMID: 11470036 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical